Delivery Order SPE2DR25D1002-SPE2DR26FGM5C
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,645.80 to AmerisourceBergen Drug Corp for the supply of Ciprofloxacin-Dexamethasone Otic Suspension (7.5mL) under a firm fixed-price contract. The award was made on November 26, 2025, with an ultimate completion date of November 28, 2025. This is a competitively awarded, non-set-aside delivery order executed out of AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $13,961.35 to AmerisourceBergen Drug Corp for the supply of Ciprofloxacin-Dexamethasone Otic Suspension 7.5mL on December 3, 2025, with an ultimate completion date of December 4, 2025. The contract employs firm fixed price pricing and was competitively awarded without set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension 7.5ml, with a ceiling value of $1,692.67. This is a firm fixed-price delivery order with no set-aside designation, performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania, and is scheduled for completion by August 15, 2025. The award represents a small-value pharmaceutical procurement typical of the...
- The Defense Logistics Agency awarded a delivery order valued at $1,135.35 to AmerisourceBergen Drug Corp on June 12, 2025, for the supply of Ciprofloxacin-Dexamethasone otic suspension (7.5ML). This non-competitive, firm fixed-price delivery order is scheduled for completion by June 13, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal medical supply...
- The Defense Logistics Agency awarded a delivery order valued at $1,606.36 to AmerisourceBergen Drug Corp for the supply of Ciprofloxacin-Dexamethasone Otic Suspension (7.5ML) on December 5, 2025, with a completion date of December 8, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order valued at $1,569.12 to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension (7.5mL) on August 6, 2025, with completion targeted for August 7, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform work at its corporate office location in Conshohocken, PA 19428. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,523.36 to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension 7.5ml, with completion targeted for June 2, 2025. This competitive, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,780.32 to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension (7.5ML) on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for Ciprofloxacin-Dexamethasone Otic Suspension 7.5ML, with a ceiling value of $1,272.60 and completion deadline of August 14, 2025. This firm fixed-price, competitively awarded delivery order represents a continuation of AmerisourceBergen's established role as a critical pharmaceutical supplier to the Department of Defense. The contract carries no set-aside designation...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,594.26 for Ciprofloxacin-Dexamethasone otic suspension (7.5mL) with an ultimate completion date of June 2, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The award represents a single transaction under the company's broader...
- SPE2DR25D1002Indefinite Delivery Contract
- SPE2DR25D1002-SPE2DR26FGM5CDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,360.95 to AmerisourceBergen Drug Corp on January 7, 2026, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension 7.5ML. This firm fixed-price delivery order, which is not set-aside, represents a continuation of pharmaceutical supply services under AmerisourceBergen's broader relationship with the federal government. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of January 8, 2026. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to military healthcare programs and other federal medical institutions. This award reflects the contractor's established capability to fulfill competitive federal procurement requirements for essential pharmaceutical commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 1/6/26 |